SUMMARY -To study the effects of plasmapheresis in preparation for thymectomy, two groups of 40 patients were selected from a sample of 286 patients with myasthenia gravis examined by the first author Group 1 included patients (15 male and 25 female; age range 8-64 yrs) who underwent thymectomy without previous plasmapheresis, whereas patients in group 2 (17 male and 23 female; age range 11-61 yrs) were thymectomized after plasmapheresis. We required patients to have a minimum follow-up period of 12 months to be included in the study. A clinical evaluation protocol composed of 76 items was developed for the study. We found significant improvement in respiratory function and muscular strength in patients thymetomized after plasmapheresis. Furthermore, the combined treatment reduced cost and length of hospital stay. Therefore, we conclude that plasmapheresis should be considered as a coadjuvant to thymectomy in the treatment of myasthenia gravis.
(1) fluctuating course; (2) association with other diseases of known autoimmune etiology; (3) increase in the levels of autoantibodies; (4) increased frequency of HLA epitopes and markers for the heavy chain of immunoglobin; (5) clinical improvement with immunosuppressing drugs or following plasmapheresis. In 1960, Simpson 23 proposed an autoimmune mechanism for MG in light of the frequent co-occurrence of this disorder with other autoimmune diseases and its occurrence in the newborn. In 1966, Chang and Lee 5 isolated alphabungarotoxin from snake venom and characterized their blocking actions at the neuromuscular junction. However, it was only in 1973 that Fambrough and colleagues 12 and Ito and collaborators 15 showed that MG was related to reduced number of acetylcholine receptors at the neuromuscular junction. In addition, those investigators demonstrated that low numbers of acetylcholine receptors were correlated to the reduced amplitude of the miniature endplate potentials (MEPPS). Subsequently, Vicent and Newson-Davis 27 and Tzartos and colleagues 25 isolated anti-acetylcholine receptor antibodies in sera of MG patients. These antibodies were of the IgG class, heterogeneous in their specificity although mostly directed against subunit alpha of the receptor. From the onwards it was clear the indication of plasmapheresis and/or immunosupression with methods of treatment of MG.
We proposed to study the effect of plasmapheresis as coadjuvant for thymectomy in MG.
MATERIALS AND METHODS
We selected 80 patients from a larger group of 286 MG patients seen at the Neurology Unit of the Hospital dos Servidores do Estado, in Rio de Janeiro. All 80 patients had a thorough clinical, laboratory and neurophysiological diagnostic assessment and were followed up a minimum of 1 year. Two groups of 40 patients, matched as well as possible for age, sex and clinical characteristics, were formed for the study. There were no differences in sex distribution between the two groups (chi square = 0.409, n.s.). In addition, the groups did not differ in age (t=l .72, n.s.) or Osserman's grades (chi square= 2.85, n.s.). Therefore, the groups could be considered homogeneous at least for sex, age and Osserman's grades.
Muscular strength was assessed by the sworn and Lahey tests, and the determination of the opening of the palpebral fissure. In sworn test, the time the patient was able to keep the arms extended with the palms down was measured with a stopwatch. The Lahey test consisted of measuring the time the patient was able to keep one leg extended while sitting. The opening of palpebral fissure was taken as the difference in fissure after a 3 minute rest period and the size of fissure when the patient reported fatigue or the upper eyelid closed down, whichever occurred first. In addition to these tests, functional breathing tests were performed on all patients. The most sensitive measure of respiratory function in our study was maximum expiratory strength. Assessment of muscular strength and respiratory function was performed at admission and repeated immediately before and after the first session of plasmapheresis, and five days after thymectomy.
Thymectomy was performed according to accepted surgical procedures by transesternal approach and large mediastenical clearance.
RESULTS
A. Time course of the effects of plasmapheresis on muscle strength -There was a 100 to 250% (median of 202%) and 80 to 150% (median of 130%) increase in muscle strength after the third and fifth session of plasmapheresis, respectively, when compared to the baseline assessment.
Additionally, there was a 40 to 50 % (median of 43%) amelioration of maximum respiratory strength that was related to clinical improvement and need of medication.
B. Use of endotracheal tube before and after-surgery - Table 1 shows that 9 patients in Group 2 were intubed before surgery, but all were kept free after surgery. The remaining 3 patients kept intubed after surgery were on intubation for only 8 to 12 hours after surgery. In Group 1, 2 patients were intubed before surgery and 17 were intubed also after surgery. Clearly then there were differences between the two groups in terms of need of intubation after surgery. Table 2 indicates the complications observed in the present study after plasmapheresis.
G. Complications of plasmapheresis -
Hypothermia was seen in one patient, which was immediately corrected by heating the tubes used in plasmapheresis to prevent the development of cardiac arrhythmia.
Local infection at the region of the catheter attachment was observed in two occasions and treated with antibiotics.
Arterial hypotension occurred in 19 patients, but had no clinical significance.
Other complications included hemolysis, transitory kidney insufficiency, hypocalcemia, urticaria, shrivering, fever and paresthesia.
Our data indicate that the higher cost of plasmapheresis is more than compensated for by the much shorter hospital stay required for this procedure. Therefore, we would recommend it for myasthenia gravis patients.
COMMENTS
The basic defect in MG involves an antibody-mediated autoimmune attack of neuromuscular junction that induces a decrease in the number of acetylcholine receptors at the postsynaptic site.
The antibodies are of IgG class, have heterogeneous specificity (polyclonal) 18 ' 25 and attach to the main immunogenic region of the alpha subunit of the acetylcholine receptor 1822 -2527 .
Since the pathogenic IgG is produced in lymphoid tissue and has to go through the circulation to reach the endplate, it can be removed by plasmapheresis. IgG is composed of two fractions: an intravascular fraction (55% of total) and an extravascular fraction (the remaining 45%). After a series of plasmapheresis, the intravascular fraction is rapidly withdrawn, the extravascular component passes to the intravascular space. This is followed by a progressive reduction of synthesized IgG and consequently of the extravascular fraction that probably allows for the improvement of clinical conditions 10 ' 20 . Methodological aspects of plasmapheresis such as volume withdrawn, frequency and immunoglobin synthesis are too important to consider. An immunosuppressant regimen should also be added to maintain the beneficial effects of plasmapheresis.
Plasmapheresis allows the withdrawal of approximately 88% of the antibody antireceptor of the intravascular space. After 36 hs, a new balance between the intra and extravascular sectors is established. Forty-eight hours after the new steady state is achieved, antibody levels are again 50% higher. A protocol of three sessions, one session daily, on alternate days, induces the elimination of 83% of the antireceptor antibodies. This rate of elimination allows a marked improvement in clinical conditions. Under these circumstances, surgery carries a lesser risk for the patient.
In our unit, a cost benefit analysis would favor a somewhat simplified procedure comprised of 5 sessions of plasmapheresis (one session a day on alternate days) 16 with a capillary type of plasma separator, anticoagulants and a double light catheter in a deep vein (e.g., femoral), and the use of several reposition solutions (for example, Ringer-albumin, Ringer-plasma, serum-albumin, serum-plasma).
The possibility of contamination of blood derivatives by viruses (HIV, hepatitis and others) favors the use of albumin or solutions not containing blood constituents. We have been using in our unit a solution of Ringer-dextran as fluid of reposition. A study comparing several solutions is in progress and will be reported shortly.
Complications related to plasmapheresis should be immediately recognized and treated. In our experience, the most common complications were allergies, fever and hemodynamic alterations. Fever and allergy occur mostly due to the reposition fluid in the absence of corticosteroids. Citrate may induce dysesthesia and nausea when used as an anticlotting agent. Hypothermia and shivers should be immediately treated as they can cause severe cardiac arrhythmia. These two complications are more common with plasmapheresis by filtering as compared to centrifuging. It should be emphasized that all the complications we have observed were easily managed.
It is our opinion that plasmapheresis is indicated for the preparation of the patient for thymectomy. Other indications for plasmapheresis would include the rebound effects after immunosuppressors, pulmonary insufficiency and in cases where other therapies failed to improve the clinical conditions of myasthenic patient. In addition, a modified procedure could be used in neonatal MG. Compared to plasmapheresis, corticoids before thymectomy induced several complications that led to a significant prolongation of hospital stay. A detailed comparison of corticoid and plasmapheresis before thymectomy will be reported by our group.
